• LAS VEGAS, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Digital Therapeutics Market is a sub division of healthcare that uses advanced technologies such as apps, devices or software that offers range of online healthcare services as to treat various medical conditions. (globenewswire.com)
  • NEEDHAM, Mass., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a late clinical stage biopharmaceutical company focused on helping patients fight cancer with oncolytic viral immunotherapies, today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update. (yahoo.com)
  • The global mRNA Vaccines market is estimated at US$11,773.3 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033. (visiongain.com)
  • The global Neurology Clinical Trials market is valued at US$9,609.2 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033. (visiongain.com)
  • According to the latest report by IMARC Group, titled ' Osteoarthritis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,' the global osteoarthritis therapeutics market reached a value of US$ 7.3 Billion in 2022. (imarcgroup.com)
  • Bicycle Therapeutics plc today announced that management will participate in a fireside chat at the SVB Securities Global Biopharma Conference on February 15th, 2023 at 9:20 a.m. (biospace.com)
  • Bicycle Therapeutics plc today announced that monotherapy dose escalation results of the ongoing Phase I/II trial of BT8009, a second-generation BTC™ targeting Nectin-4, will be presented at the 2023 American Society for Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, being held February 16-18, 2023 in San Francisco, California. (biospace.com)
  • Headlining a recent virtual NTI Seminar, COVID-19: Vaccines, Therapeutics, and the Biosecurity Nexus , the former U.S. Food and Drug Administration commissioner and internationally recognized expert on health security and vaccine development said that despite the sobering pandemic statistics, there has been "an amazingly bright spot in the response, which has been seeing the fruits of the investments in science. (nti.org)
  • A global review of rabies vaccines for human use. (cdc.gov)
  • Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies. (bvsalud.org)
  • LEXINGTON, Mass.--( BUSINESS WIRE )-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference. (businesswire.com)
  • Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq:CARA) today announced positive topline data from Cara's KALM-2 pivotal phase-III trial of KORSUVA™ (CR845/difelikefalin) Injection in haemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP). (pharmiweb.com)
  • 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large market diseases, has announced that it priced an upsized underwritten public offering of 7,500,000 shares of its common stock at a public offering price of US$16.00 per share. (lw.com)
  • Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced monotherapy Phase I dose escalation results of the ongoing Phase I/II trial of BT8009, a novel BTC™ targeting Nectin-4. (biospace.com)
  • Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported financial results for the third quarter ended September 30, 2022 and provided recent corporate updates. (biospace.com)
  • North America held the largest share of the global digital therapeutics market in 2016, owing to the presence of numerous digital therapeutics providers in the region focusing on technological advancements and high adoption of advanced medical solutions. (globenewswire.com)
  • Will North America continue to be the most profitable market for warts therapeutics providers? (bccresearch.com)
  • North America dominates the global bipolar disorder therapeutics market due to new product innovation, increased awareness among people about bipolar disease, and rise in prevalence of bipolar disorders. (medgadget.com)
  • Geographically the global oropharyngeal cancer diagnosis and therapeutics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. (researchandmarkets.com)
  • North America is the largest market for next-generation antibody therapeutics. (sbwire.com)
  • The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. (bharatbook.com)
  • North America, Asia-Pacific, Latin America, Middle East & Africa, and Europe are key regional segments of fibromyalgia therapeutics market. (zionmarketresearch.com)
  • North America dominated the fibromyalgia therapeutics market in 2018. (zionmarketresearch.com)
  • The global lysosomal storage diseases therapeutics market is segmented into the five key regions of North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). (persistencemarketresearch.com)
  • North America is expected to be the second most lucrative market in the global lysosomal storage diseases therapeutics market over the forecast period. (persistencemarketresearch.com)
  • LONDON: Pfizer Inc. on Monday agreed to pay $5.4 billion in cash for sickle cell disease drugmaker Global Blood Therapeutics, as it looks to capitalize on a surge in revenue from its COVID-19 vaccine and treatment. (arabnews.com)
  • With the acquisition of Global Blood Therapeutics, Pfizer adds sickle cell disease treatment Oxbryta, which was approved in 2019 and is expected to top $260 million in sales this year. (arabnews.com)
  • Global Blood Therapeutics Inc ( GBT ) has recently begun commercializing Oxbryta (Voxelotor). (seekingalpha.com)
  • With billions of dollars from the covid vaccine windfall, pharmaceutical giant Pfizer is reportedly in late-stage negotiations to buy the drug maker Global Blood Therapeutics (GBT) for $5 billion, The Wall Street Journal reported Friday. (techstartups.com)
  • Founded in 2011 by Andrej Sali, Charles Homcy, Craig Muir, David Phillips, Jack Taunton, and Matthew Jacobson, Global Blood Therapeutics is a clinical-stage biopharmaceutical company with the goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder. (techstartups.com)
  • New analysis from Frost & Sullivan, A Competitive Analysis of the Global Breast Cancer Therapeutics Market , finds that the market earned revenues of approximately $10.0 billion in 2014 and estimates this to reach $13.38 billion in 2018 . (news-medical.net)
  • The report provides revenue of the global warts therapeutics market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. (bccresearch.com)
  • A new market study, titled "Global Biopolar Disorder Therapeutics Market Research Report 2018", has been featured on WiseGuyReports. (medgadget.com)
  • To analyze and study the global Biopolar Disorder Therapeutics sales, value, status (2013-2017) and forecast (2018-2025). (medgadget.com)
  • Some of the key players include Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A. (imarcgroup.com)
  • Research and Markets has announced the addition of the "Global Asthma Therapeutics Market 2016-2020" report to their offering. (prnewswire.com)
  • The report forecasts the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020. (prnewswire.com)
  • TMR's report on the global warts therapeutics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030. (bccresearch.com)
  • What will be the Y-o-Y growth of the global warts therapeutics market between 2020 and 2030? (bccresearch.com)
  • The global effects of the COVID-19 pandemic are already being seen, and the Alzheimer's disease medicines and diagnostic market was greatly impacted in 2020. (medgadget.com)
  • By 2020, the global dilated cardiomyopathy therapeutics market is projected to be worth US$328.6 million which shows a decline of 7% CAGR from. (cyberessays.com)
  • Digital therapeutics market is expected to witness high growth during forecast period owing to number of factors such as increase in geriatric population that require home healthcare services, rise in incidence of chronic diseases, increase in demand for cost effective healthcare infrastructure, high adoption rate of technologically advanced products, high investments from various institutes and government initiatives for development and commercialization of digital therapeutics medicines. (globenewswire.com)
  • Emerging market such as India and China are poised to witness favorable growth over the forecast period due to rising awareness about digital therapeutics solutions and increasing focus on advancement in healthcare infrastructure in the region. (globenewswire.com)
  • Entrance of global players in these emerging markets will further boost the market growth. (globenewswire.com)
  • The report also provides the compound annual growth rate (CAGR) for the global warts therapeutics market during the forecast period. (bccresearch.com)
  • What is the scope of growth of product companies in the global warts therapeutics market? (bccresearch.com)
  • Which factors are anticipated to hamper the growth of the global warts therapeutics market during the forecast period? (bccresearch.com)
  • A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global warts therapeutics market and arrive at conclusions on its growth prospects. (bccresearch.com)
  • Rise in prevalence of bipolar disorder, high unmet medical needs, technological advancement and government initiatives are the key factors accelerating the growth of the bipolar disorder therapeutics market. (medgadget.com)
  • The market study of the global oropharyngeal cancer diagnosis and therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. (researchandmarkets.com)
  • This report covers the present scenario and the growth prospects of the global liver diseases therapeutics market for 2015-2019. (prnewswire.com)
  • The report covers the landscape of the global liver diseases therapeutics market and its growth prospects in the coming years. (prnewswire.com)
  • However, rigorous restrictions and a lengthy approval process for Alzheimer's disease diagnostics and therapeutics, as well as the expiration of several patent medications, are some of the primary factors limiting the worldwide Alzheimer's disease patient market's growth. (medgadget.com)
  • A dearth of knowledge about experimental treatments used to cure Alzheimer's disease is also a big growth stumbling block for the worldwide Alzheimer's disease therapeutics and diagnostics market. (medgadget.com)
  • The acquisition of Beckley Canopy will allow Spectrum Therapeutics to continue expanding its medical cannabis leadership around the world, strengthening our foothold in the UK and more broadly across Europe - a region that wants to see stronger clinical evidence around cannabis-based medicines," said Mark Zekulin , CEO, Canopy Growth Corporation. (newswire.ca)
  • Globally, the next-generation antibody therapeutics market is witnessing significant growth due to technological advancements in antibody therapeutics and increasing the prevalence of chronic diseases. (sbwire.com)
  • In addition, rising healthcare expenditure and growing R & D activities are driving the growth of the next-generation antibody therapeutics market. (sbwire.com)
  • The report sheds light on various uncertainties such as the economic slowdown of major economies, negative & positive influencing factors, fluctuations in the market value, the high growth rate of the industry, and developments in the global Follicular Lymphoma Drugs market. (bignewsnetwork.com)
  • The report offers a comprehensive study of the industry and information about the expected future trends that will have a significant impact on the growth of the global Follicular Lymphoma Drugs market during the 2022-2028 period. (bignewsnetwork.com)
  • A favourable growth element for the global Branded PAH Therapeutics market is propelled by increasing prevalence, advancement in research and development, evolving treatment landscape and regulatory approvals. (reportsnreports.com)
  • New drug discoveries and improved therapies drive branded PAH therapeutics growth. (reportsnreports.com)
  • There is a high rate of growth in the usage of technology for Therapeutics, especially in developed markets, as consumers are aware of the advanced products for treating medical conditions. (strategicmarketresearch.com)
  • An increasing diagnosis rate due to rising awareness and financial incentives for orphan drug development to recover R&D costs is the primary factor fueling the growth of the global lysosomal storage diseases therapeutics market. (persistencemarketresearch.com)
  • However, heterogeneity of the disease leading to underdiagnoses of lysosomal storage diseases, lack of treatment options, and high cost of treatment are factors likely to hamper the growth of the global lysosomal storage diseases therapeutics market over the forecast period. (persistencemarketresearch.com)
  • Aldeyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies designed to treat immune-mediated diseases. (businesswire.com)
  • Vifor Pharma has announced the acquisition of Sanifit Therapeutics, a Spanish clinical-stage cardio-renal biopharmaceutical company focused on treatments for end-stage kidney disease patients with progressive vascular calcification disorders, and Inositec AG, a Swiss company, developing first-in-class non-dialysis treatments for soft tissue and vascular calcification disorders. (menafn.com)
  • Research and Markets ( http://www.researchandmarkets.com/research/hfrlrr/global_liver ) has announced the addition of the "Global Liver Diseases Therapeutics Market 2015-2019" report to their offering. (prnewswire.com)
  • The report, Global Liver Diseases Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. (prnewswire.com)
  • With the acquisition of C3, and Canopy Growth's expanding research and development plans worldwide, the Company is solidifying its status as a truly global leader in cannabinoid research. (newswire.ca)
  • Once the acquisition is complete, Beckley Canopy will be fully integrated into the current Spectrum Therapeutics platform and management team in Europe , a region of focus for the Company as policy surrounding medical cannabis and patient access continues to evolve. (newswire.ca)
  • Under the terms of the acquisition agreement, Vifor Pharma will acquire 100% of the outstanding shares in Sanifit Therapeutics, receiving full global rights for SNF472, further enhancing the company's portfolio of innovative assets. (menafn.com)
  • In November 2016, it was rumored that Endo was considering selling Paladin back to Knight Therapeutics, for less than it initially paid for it. (wikipedia.org)
  • The Enzyme replacement therapy (ERT) segment is estimated to account for 94.7% revenue share of the global lysosomal storage diseases therapeutics market by 2016 end. (persistencemarketresearch.com)
  • The Hospitals end user segment is anticipated to account for 66.9% revenue share of the global lysosomal storage diseases therapeutics market by 2016 end while the Clinics end user segment accounted for 33.6% revenue share and was valued at US$ 1,714.4 Mn in 2015. (persistencemarketresearch.com)
  • In terms of value, Europe is estimated to be the dominant market in the global lysosomal storage diseases therapeutics market in 2016 and is expected to register a CAGR of 10.2% over the forecast period to reach a market valuation of US$ 5,105.1 Mn by 2026 end. (persistencemarketresearch.com)
  • The Asia Pacific lysosomal storage diseases therapeutics market is anticipated to represent absolute $ opportunity of US$ 59.1 Mn in 2017 over 2016. (persistencemarketresearch.com)
  • The companies operating in the global digital therapeutics market emphasize on product development coupled with technological advancements to secure competitive advantage in the market. (globenewswire.com)
  • The report also provides insights on the risk involved for new entrants as well as existing players in the global Follicular Lymphoma Drugs market considering factors such as key trends, technological advancements and also provides emphasis on a solution to overcome the risk. (bignewsnetwork.com)
  • Secondary sources referred to by analysts during the production of the global warts therapeutics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. (bccresearch.com)
  • Biocon Biologics India Limited , a fully integrated 'pure play' biosimilars company, a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), and Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960) , a leader in digital therapeutics, today announced a global collaboration agreement between Biocon Biologics' subsidiary Biocon Sdn. (biocon.com)
  • Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. (wikipedia.org)
  • In 1995, Jonathan Ross Goodman and Mark Beaudet founded Paladin Labs, the predecessor company to Knight Therapeutics. (wikipedia.org)
  • Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in the following investor conferences in March. (biospace.com)
  • As per our research report, the global Alzheimer's disease therapeutics and diagnostics market size is forecasted to be growing at a CAGR of 4.67% from 2022 to 2027 and value USD 14844 million by 2027 from USD 11815 million in 2022. (medgadget.com)
  • Some of the major factors driving the worldwide Alzheimer's disease therapeutics and diagnostics market are an increase in the senior population, an increase in healthcare expenditure, and higher government funding. (medgadget.com)
  • In addition, rising healthcare awareness and innovative Alzheimer's disease diagnostic technologies are propelling the worldwide Alzheimer's disease diagnostics and therapeutics market forward. (medgadget.com)
  • and Asia Pacific-Japan & China) Outlook 2024" provides information on the current scenario, detailed market outlook of the global radiopharmaceutical market with detailed analysis of market segments such as Diagnostics & Therapeutics. (bharatbook.com)
  • Spectrum Therapeutics will leverage Beckley Canopy's intellectual property, accelerate its comprehensive research programs, build evidence around the Company's products and formulations and ultimately improve patient access to cannabinoid-based medicines globally. (newswire.ca)
  • The dilated cardiomyopathy therapeutics market globally in terms of drug class is broadly classified as angiotensin-converting enzyme (ACE) inhibitors, beta blockers, aldosterone antagonists, and angiotensin II receptor blockers (ARBs). (cyberessays.com)
  • Alzheimer's disease medicine and technology research and development has been hampered by a global supply chain disruption and the incapacity of people 65 and older to participate in clinical studies. (medgadget.com)
  • The lead analyst of the report commented the Alzheimer's disease therapeutics market has been stagnant over the last few years, with many drugs failing late stage clinical trials. (visiongain.com)
  • Moreover, with the usage of AI in digital-therapeutics, the early symptoms of some serious diseases like diabetes, dementia, Alzheimer's disease, etc. can be easily detected. (strategicmarketresearch.com)
  • The global digital therapeutics market will witness a robust CAGR of 31.4%, valued at $3.02 billion in 2021, expected to appreciate and reach $35.78 billion by 2030, confirms Strategic Market Research. (strategicmarketresearch.com)
  • Over the past few years, investments by digital- therapeutics organizations for patient healthcare in USA have increased by an average of 40% per year, thereby reaching more than USD 1 billion in 2021. (strategicmarketresearch.com)
  • For Sepsis Awareness Month 2021, we can draw several lessons from global efforts to track and mitigate the impact of COVID-19, or SARS-Cov-2 infection. (cdc.gov)
  • On the basis of therapeutic application, oncology is the largest segment in next-generation antibody therapeutics market. (sbwire.com)
  • The antiepileptic drugs segment also accounted for equal share in the fibromyalgia therapeutics market as Pregabalin and Gabapentin are major antiepileptic drugs prescribed for fibromyalgia treatment. (zionmarketresearch.com)
  • The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. (persistencemarketresearch.com)
  • This segment is expected to continue to lead the global lysosomal storage diseases therapeutics market during the forecast period. (persistencemarketresearch.com)
  • The dilated cardiomyopathy therapeutics market worldwide is segregated on the basis of drug class, pipeline drugs, and geography. (cyberessays.com)
  • Diabetes market is expected to grow at a fastest CAGR over the forecast period due to a rise in the global prevalence of diabetes. (globenewswire.com)
  • Once developed, the Insulia ® digital companion will be offered to people with Type 2 diabetes using Biocon Biologics' insulins, in key global markets. (biocon.com)
  • U.S. dominates the North American digital therapeutics market due to growing prevalence of chronic diseases coupled with increasing geriatric population and high adoption of technologically advanced devices. (globenewswire.com)
  • The global market is majorly driven by the increasing prevalence of osteoarthritis. (imarcgroup.com)
  • Such conditions are progressive with age, and with the high prevalence of the geriatric population, the overall size of the digital therapeutics market is projected to rise exponentially. (strategicmarketresearch.com)
  • Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. (news-medical.net)
  • Although Herceptin and Tykerb are the only targeted therapeutics available for breast cancer, the recently approved Kadcyla and Perjeta will bolster the portfolio of targeted drugs. (news-medical.net)
  • Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics. (cdc.gov)
  • What is the influence of changing trends in treatment procedures on the global warts therapeutics market? (bccresearch.com)
  • It evaluates the impact of various crucial industry trends as well as recent developments on the overall demand dynamics in the global Follicular Lymphoma Drugs market. (bignewsnetwork.com)
  • This global Follicular Lymphoma Drugs market report studies the trends in consumer and supply chain dynamics that have been observed to be helpful in developing production strategies for the industry. (bignewsnetwork.com)
  • Roche, Seattle Genetics, Takeda, Dyax Corp., and Immunogen are some of the leading players in the global market of next-generation antibody therapeutics. (sbwire.com)
  • Furthermore, the report sheds light on the changing competitive dynamics in the global warts therapeutics market. (bccresearch.com)
  • The report delves into the competition landscape of the global warts therapeutics market. (bccresearch.com)
  • Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global warts therapeutics market with accuracy. (bccresearch.com)
  • This report studies the global Biopolar Disorder Therapeutics market status and forecast, categorizes the global Biopolar Disorder Therapeutics market size (value & volume) by key players, type, application, and region. (medgadget.com)
  • Weekly Report described 5 cases of Pneumocystis the United Nations behind the search for a global pneumonia in gay men ( 1 ). (cdc.gov)
  • The global oropharyngeal cancer diagnosis and therapeutics market are segmented based on the diagnostic type, treatment type, and end-users. (researchandmarkets.com)
  • AI-enabled digital-therapeutics provide adeqaute diagnosis & personalized care as well as anticipates the variety of challenges and requirements based on patient's behavior. (strategicmarketresearch.com)
  • Next-generation antibody-based therapeutics enhances existing properties of therapeutic antibodies for the treatment of various medical conditions such as cancer, infectious diseases, and autoimmune diseases. (sbwire.com)
  • Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which finds applications in clinical areas for diagnostic or therapeutics of human diseases. (bharatbook.com)
  • Other factors driving the global demand for lysosomal storage diseases therapeutics include a faster uptake and faster market access, premium product pricing, and increasing focus of pharmaceutical companies in the research and development of drugs for the treatment of rare diseases. (persistencemarketresearch.com)
  • Advent of therapies targeting neuropathic pain management manifestations by crossing blood brain barrier (BBB) and therapies that overcome immune response and have better tissue selectivity will define the future landscape of the global lysosomal storage diseases therapeutics market. (persistencemarketresearch.com)
  • Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global warts therapeutics market. (bccresearch.com)
  • Increase in investment in research and development and collaboration activities between companies for product development are the other factors likely to propel the bipolar disorder therapeutics market. (medgadget.com)
  • The research arm in turn directly supports the commercial efforts of Spectrum Therapeutics around the world. (newswire.ca)
  • Canopy Growth's medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. (newswire.ca)
  • A zoliflodacina, um novo antibiótico oral, primeiro da classe e um dos únicos tratamentos em desenvolvimento para enfrentar a crescente ameaça da gonorreia multirresistente, entrará em ensaios decisivos graças a uma colaboração entre a Parceria Global para Pesquisa & Desenvolvimento em Antibióticos (GARDP, na sigla em inglês de Global Antibiotic Research and Development Partnership ), e Entasis Therapeutics. (dndi.org)
  • The market research study on Global Follicular Lymphoma Drugs Market from 2022 to 2028 conducted by MarketsandResearch.biz contains remarkable data along with a future forecast and thorough analysis of the market on an international and regional level. (bignewsnetwork.com)
  • Pulmonary hypertension is becoming an increasingly common global health issue, according to The Pulmonary Vascular Research Institute Pulmonary arterial hypertension (PAH), especially the idiopathic form, although still a rare disease with an incidence of 2 5 per million adults, is increasingly being diagnosed in elderly people. (reportsnreports.com)
  • Explore translational medicine and therapeutics research with this Newcastle University MRes course. (ncl.ac.uk)
  • Translational medicine and therapeutics is a competitive research area. (ncl.ac.uk)
  • You'll study subject-specific content in transitional medicine and therapeutics research. (ncl.ac.uk)
  • Nick Cammack, COVID-19 Therapeutics Accelerator Lead at Wellcome, said: "Investment in research is the world's only exit strategy from COVID-19. (mastercard.com)
  • Members of the research group are involved in several national and international collaborations such as Umeå University, the SSNAP quality register in the UK, and the Global Burden of Disease group at the Institute for Health Metrics and Evaluation (IHME), University of Washington, US. (lu.se)
  • Bicycle Therapeutics plc today announced that it has entered into a strategic collaboration agreement with Novartis to develop, manufacture and commercialize Bicycle® radio-conjugates (BRCs) for multiple agreed upon oncology targets. (biospace.com)
  • This collaboration will help patients around the globe achieve optimal outcomes on their insulin journey, and illustrates digital therapeutics' growing importance as part of the new standards of care. (biocon.com)
  • Focuses on the key Biopolar Disorder Therapeutics manufacturers, to study the sales, value, market share and development plans in future. (medgadget.com)
  • As the world's population ages, the incidence of osteoarthritis is expected to increase, making the development of effective osteoarthritis therapeutics an essential and growing field. (imarcgroup.com)
  • These grants mark the first investments to come from the COVID-19 Therapeutics Accelerator, a large-scale initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard to speed the development of and access to therapies for COVID-19. (mastercard.com)
  • In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. (lu.se)
  • PTC Therapeutics Inc. priced its previously announced public offering of 4 million shares at $27.04 per share. (spglobal.com)
  • There are currently several types of osteoarthritis therapeutics available, including pain management medications, joint injections, and physical therapy. (imarcgroup.com)
  • When many countries are looking inwards more than ever before, what we really need are more integrated and global strategies for pandemic threats. (nti.org)
  • Today, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three institutions-the University of Washington, University of Oxford, and La Jolla Institute for Immunology-to fund clinical trials in order to identify highly potent immunotherapies for the COVID-19 pandemic. (mastercard.com)
  • Investing now, at scale, in the COVID-19 Therapeutics Accelerator is vital if we are to change the course of this pandemic. (mastercard.com)
  • Given this context, AFR is engaging in global and regional efforts to support the Member States and partners in improving productivity, efficiency and attaining a sustainable approach to managing a protracted COVID-19 pandemic. (who.int)
  • Background: Coronavirus pandemic, a serious global public health threat, affects the Southern African countries more than any other country on the continent. (bvsalud.org)
  • t https://unctad.org/system/files/official- document/aldcmisc2020d3_en.pdf. (who.int)
  • We are excited to partner with Biocon Biologics, a leading global player committed to expanding patients' access to premier biologics while caring about treatment affordability. (biocon.com)
  • Bicycle Therapeutics plc today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Bicycle's BT8009 monotherapy for the treatment of adult patients with previously treated locally advanced or metastatic urothelial cancer. (biospace.com)
  • Not only are miRNA global regulators of gene expression, but also miRNA-based therapeutics provide a realistic treatment modality. (cdc.gov)
  • Market Study by Global Industry Analysts, Inc. (strategyr.com)
  • Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global warts therapeutics market. (bccresearch.com)
  • Digital therapeutics is a high revenue market which involves use of telemedicine technology for monitoring and providing better healthcare treatments to patients. (globenewswire.com)
  • Going forward, by extending the Insulia ® platform to its complete range of insulin products, including Recombinant Human Insulin, Insulin Glargine and Insulin Aspart, Biocon Biologics will create a comprehensive digital therapeutics portfolio for patients. (biocon.com)
  • Furthermore, in the healthcare sector, digital-therapeutics has augmented the usage of A.I., as well as virtual reality for solving a plethora of problems that exist in the industry. (strategicmarketresearch.com)
  • A.I. plays a significant role in digital-therapeutics by increasing the engagement of the software-based treatments. (strategicmarketresearch.com)
  • For example, the advent of AI in digital-therapeutics has adequately guided healthcare professionals to understand the daily patterns & requirements of the patients, which, in turn, enabled them to provide much better guidance and support. (strategicmarketresearch.com)
  • The SPH Portal is an interactive digital platform that facilitates the sharing and exchange of information regarding multisectoral health security investments, activities, and capacities at national, regional, and global levels. (who.int)
  • Based on the therapeutic type, due to its enormous user base, the Marketed Drugs sector is expected to lead the worldwide Therapeutics market. (medgadget.com)
  • Knight Therapeutics, like Paladin Labs before it, focuses on marketing and licensing drugs from international drug makers for the Canada and Latin America. (wikipedia.org)